| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |